ALL HYPOTHESES
Repurposing candidates for upadacitinib
Type 2 diabetes 1
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| C-reactive protein | type 2 diabetes | 0.230 | Mid | novel signal | none |
ALL HYPOTHESES
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| C-reactive protein | type 2 diabetes | 0.230 | Mid | novel signal | none |